ELISA Kit for Fibulin 3 (FBLN3) View larger

ELISA Kit for Fibulin 3 (FBLN3)

CC-SEF422Hu

New product

48T, 96T, 96T×5, 96T×10, 96T×100

More details

Registe-se for viewing this price!

Ao comprar este produto pode ganhar até 7 pontos de fidelização. Seu carrinho totalizará 7 pontos de fidelização que podem ser convertidos num vale de desconto de 28.00EUR.


Data sheet

Size 96T
Storage Conditions -20°C
Shipping Conditions Entre 4°C y 8°C
Applications Enzyme-linked immunosorbent assay for Antigen Detection.
Detection Range 1.56-100ng/mL
Sensitivity The minimum detectable dose of this kit is typically less than 0.64ng/mL
Research Area Metabolic pathway
Organism species Homo sapiens (Human)
Alternative Names EFEMP1
Item Name Fibulin 3
Assay Length 3h
Method Double-antibody Sandwich
Sample Type Serum, plasma, urine and other biological fluids
Formato 48T, <i>96T</i>, 96T×5, 96T×10, 96T×100
Test Principle The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Fibulin 3 (FBLN3). Standards or samples are then added to the appropriate microtiter plate we
Assay procedure summary 1. Prepare all reagents, samples and standards
UniProt ID Q12805

More info

Click here for manual in PDF

Click here for OD Image


CITATIONS
Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma;YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis.;Role of fibulin-3 in lung cancer: In vivo and in vitro analyses;Discovery of new biomarkers for malignant mesothelioma;DIAGNOSIS OF CELL PROLIFERATIVE DISEASES;Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma;Value of plasma and pleural effusion fibulin-3 levels in the diagnosis of malignant pleural mesothelioma effusions;Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma;Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis;Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.;Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study ;HMGB1 and its hyperacetylated isoform are sensitive and specific serum biomarkers to detect asbestos exposure and to identify mesothelioma patients;Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational …;Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma.;A Novel Panel of Serum Biomarkers for MPM Diagnosis.;Association of fibulin-3 concentrations with the presence and severity of knee osteoarthritis: A cross-sectional study;Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population;Placental protein 14 as a potential biomarker for diagnosis of preterm premature rupture of membranes;The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion;Fibulin-3 and other cartilage metabolism biomarkers in relationship to calprotectin (MRP8/14) and disease activity in rheumatoid arthritis patients treated with …;Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals;